The mechanisms that drive disease have long confounded the medical industry. How much of a part does genetics play? How does the patient’s lifestyle influence his or her risk of developing cancer? What makes one patient respond favorably to a particular treatment, while another suffers severe side effects?
Browsing: Video
Inovio Biomedical’s electroporation technology uses brief, controlled electrical pulses to increase cellular uptake of gene expression in DNA-based treatments; this enhances the potency of DNA-based immunotherapies against cancers and infectious diseases. Inovio has an extensive patent portfolio and line of devices and prototypes for electroporation-based DNA delivery. Interim clinical data from multiple studies has indicated safety and tolerability, heightened levels of antibody and T-cell immune responses, and durable local and systemic tumor responses – providing initial validation of electroporation’s ability to enhance DNA vaccine potency. The company licenses its technology and works through collaboration. Current partners include: Merck (cancers) Wyeth…
One of the central problems in using chemotherapy to treat cancer is its harmful effect on organ health. Lower dosages of the drug are often used to limit side effects, which may diminish benefits of the therapy. Delcath Systems has developed a drug delivery system that isolates the liver from the circulatory system. It allows chemotherapy agents to be administered to the liver and filters those agents from the blood before returning it to general circulation. The company is currently focused on delivering chemotherapy agents via its Percutaneous Hepatic Perfusion (PHP) system in patients with inoperable liver metastases. This process…
Our in-house dynamo, Claudia Pinzon and the rest of the the talented team at OneMedTV, have been busy compiling a wealth of valuable video content captured at AdvaMed2008. Below, some of that footage. To watch the videos, click the thumbnail or visit OneMedPlace.tv. Veralight: David VanAvermaete from Veralight presents a new approach to non-invasive diabetes screening through earlier detection and complication reduction. Microtransponder: T. Jordan Curnes from Microtransponder talks about a wireless neurostimulation device for chronic pain management. BioControl: BioControl speaks about their latest innovations in the pathogen detection space. Chemica Technologies: Chemica Technologies is a research-oriented, biotechnology-focused company. Mesynthes:…
POM Wonderful was founded by Stewart and Lynda Rae Resnick, who purchased a 100-acre pomegranate orchard in 1987. The company launched its namesake juice in 2002. From 2003 to 2006, annual sales climbed from $12 million to $91 million. The company is now the largest grower and distributor of pomegranates and pomegranate juice in the U.S. This must be some seriously profitable juice. Since inception, POM has banked on its health benefits. The company has invested more than $23 million in scientific research to support marketing claims. Packaged in precious containers, the juice sells for +/- $4.50 per16-ounce bottle. We…
Bostwick Laboratories is a full-service laboratory specializing in uropathology. The company’s pathologists specialize in the diagnosis, treatment and subsequent management of prostate cancer, kidney disease, cancer of the bladder and other urologic conditions. Bostwick offer complete histologic services, including tissue processing with routine and special stains. DNA ploidy analysis is offered on prostate biopsies with cancer. Bostwick also render second opinions on challenging cases referred by physicians and patients. The company’s laboratory is actively involved in clinical and basic research.
Maple Leaf HIFU Co. offers Ablatherm High Intensity Focused Ultrasound (HIFU) treatment for localized prostate cancer. During the procedure, a probe is placed into the rectum after spinal or epidural anesthesia has been administered. This probe emits a beam of high intensity focused ultrasound. At the point where the ultrasound is focused the sudden and intense absorption of the ultrasound beam raises the temperature which destroys targeted cells. The area destroyed by each beam is very small and precise. By repeating the process and moving the focal point it is possible to destroy the prostate tissue. The treatment takes from…
Prostate cancer is the second leading cause of cancer death in men. The cancer stems from a malignant tumor that originates in the prostate gland. As the tumor grows it can spread to other areas of the body, including nearby lymph nodes, bones and organs. In the past 20 years, five-year survival rates for all stages of prostate cancer combined have increased from 67% to 99% due to advances in medical technology and detection equipment. There are approximately 1.30 million prostate biopsies performed in the U.S. each year. Envisioneering has developed a scanning technology that improves accuracy and outcomes of…